Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PPFIA1 pseudogene 1 (PPFIA1P1) is a non-coding pseudogene related to the functional gene PPFIA1, which encodes liprin-alpha-1, a member of the LAR protein-tyrosine phosphatase-interacting protein (liprin) family[2][4][1]. No evidence exists that PPFIA1P1 encodes a functional protein or has any established biological or therapeutic relevance. All well-described functions, disease roles, and research studies relate to the protein-coding gene PPFIA1, not its pseudogene[1][2][4][5]. As a result, PPFIA1P1 is not considered a therapeutic target, has no described protein product, and does not interact with any known drugs.
None (pseudogenes are not targeted by drugs and do not possess a defined mechanism of action)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PPFIA1 pseudogene 1 (PPFIA1P1).